The mRNA therapeutics and vaccines market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors.
This can be attributed to the various benefits offered by these therapeutic modalities, such as ease of administration, higher biological efficacy, enhanced potent immunogenicity and versatile delivery platforms at reduced toxicity levels.
The financial opportunity within the mRNA therapeutics and mRNA vaccines market has been analyzed across the following segments:
§ Routes of Administration
§ Intradermal
§ Intravenous
§ Intranasal
§ Others
§ Mrna Therapeutic Area
§ Infectious Diseases
§ Oncological Disorders
§ Other Disorders
Key Geographical Regions
§ North America
§ Europe
§ Asia-Pacific
§ Latin America
§ Middle East and North Africa
The mRNA Therapeutics and mRNA Vaccine Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
§ Arcturus Therapeutics
§ BioNTech and Pfizer
§ CureVac
§ Gennova
§ Moderna
§ Walvax
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Overview
5. Competitive Landscape
6. mrna companies Competitiveness Analysis
7. Drug Profiles
8. Big Pharma Initiatives
9. Start-Up Health Indexing
10. Clinical Trial Analysis
11. Partnerships and Collaborations
12. Funding and Investment Analysis
13. Patent Analysis
14. Market Forecast and Opportunity Analysis
15. Market Forecast and Opportunity Analysis
16. Conclusion
17. Appendix 1: Tabulated Data
18. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html
Learn from experts: do you know about these emerging industry trends?
Novel Antibody Therapies: Addressing Unmet Needs for Oncological Disorders
Manufacturing Execution Systems: A Necessity for Healthcare Industry
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
English